Mounjaro injection pens: what the clinical evidence tells you

What the pen actually contains, and why the dose schedule matters

The Mounjaro injection is delivered via a pre-filled, multi-dose KwikPen: each one holds four weekly injections, supplied by Eli Lilly and approved by the MHRA as a prescription-only medicine. UK prescribers work through six strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg) typically moving up in four-week steps, and only when the current dose is well tolerated. The starting strength exists to settle the body's response, not to produce significant weight loss in itself; expecting dramatic change at 2.5 mg often leads to frustration, and a question our prescribers hear most weeks is whether the starter dose is doing anything at all. It is. It's reducing the likelihood that the therapeutic doses later cause intolerable nausea.

The SURMOUNT programme enrolled thousands of adults across its trials, and the SURMOUNT-1 data (cited in NICE's appraisal of tirzepatide (TA1026, published December 2024)) showed that outcomes at 15 mg were meaningfully greater than at lower maintenance doses. That's why consistent titration, led by your prescriber rather than personal preference, matters. Skipping ahead doesn't speed things up; it increases the chance you'll need to step back down.

For anyone weighing up how the pen compares to other formats, our Mounjaro pens overview covers the practical differences in more detail.

Injection sites, technique and why rotation isn't optional

Tirzepatide is injected subcutaneously (into the layer of fat just beneath the skin) at one of three sites: the abdomen (avoiding the navel by a few centimetres), the front or outer thigh, or the back of the upper arm. Rotating between sites with each dose prevents lipohypertrophy, a localised thickening of fatty tissue that can develop when the same spot is used repeatedly and that slows absorption. The NHS tirzepatide page walks through this clearly, and the Patient Information Leaflet inside the box provides step-by-step illustrated guidance.

Technique itself is straightforward with a KwikPen: the needle is hidden inside the device, which helps with needle anxiety. Press the pen firmly against clean skin, hold for several seconds after the click, and the dose is delivered. There is no need to pinch the skin for most sites. If you find a particular site uncomfortable, switching to another on the next injection is fine, what matters is not repeating exactly the same spot week after week.

Alcohol swabs are useful for cleaning the skin beforehand; our pharmacy stocks alcohol swabs if you need them. Once used, the pen's needle should be disposed of in a proper sharps container, never in household waste.

For a detailed look at how site choice can affect your experience, see our page on whether injection site matters for Mounjaro.

Side effects most commonly reported with the injection, and when to act

The side-effect profile of tirzepatide is well characterised across the SURMOUNT trials and reflected in the SmPC. Gastrointestinal effects lead the list: nausea, loose stools, constipation, indigestion and, less commonly, vomiting. These are most noticeable in the first week or two after starting, or after a dose increase, and typically settle as the body adjusts. Eating smaller portions and avoiding high-fat meals shortly before and after the injection helps considerably.

More serious but infrequent effects include acute pancreatitis. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting this risk across GLP-1 medicines: severe stomach pain that spreads towards the back (with or without vomiting) warrants urgent medical attention, not a wait-and-see approach. Similarly, signs of an allergic reaction, significant swelling at the injection site that doesn't settle, or symptoms of dehydration from persistent vomiting or diarrhoea should prompt a call to a clinician or NHS 111.

Tirzepatide carries a Black Triangle (▼) designation, meaning the MHRA actively collects post-marketing safety data. Any suspected side effect can be reported via the Yellow Card scheme, patients as well as healthcare professionals can do this.

If cost is on your mind alongside these practical questions, our weight-loss treatment overview sets out the context for private prescription pricing clearly and honestly.

Storage, travel and what to do if a dose is missed

Mounjaro pens must be stored in a refrigerator at 2–8°C, away from the freezer compartment and out of direct light. If you are considering your supply options, you can order Mounjaro 2 pens or opt for Mounjaro 3 pens depending on how many weeks of treatment you want to have to hand. The exact room-temperature storage window (for travel or if the fridge isn't accessible) is stated in the Patient Information Leaflet and on the eMC SmPC for tirzepatide; follow those figures rather than any number you see quoted online, because they represent the formally tested stability data. A pen that has been left out for longer than the stated period should not be used.

Travel with injectable medicines is manageable. An insulated cool bag with an ice pack (not touching the pen directly) covers most journeys. For international travel, a letter from your prescriber confirming the prescription is worth carrying; regulations differ by country.

If a dose is missed, the decision on whether to take it late or skip to the next scheduled dose depends on how much time has passed and your current dose level. This is exactly the kind of question to put to your prescriber or pharmacist, and our guidance on Mounjaro injections covers some of the practical points around timing and scheduling that patients most often ask about. Our FAQs page covers some of the most common practical queries, and the contact page connects you with our support team if something more specific has come up.